{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:06:52Z","timestamp":1791220012331,"version":"4.1.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,4,20]],"date-time":"2010-04-20T00:00:00Z","timestamp":1271721600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1038\/nrneurol.2010.35","type":"journal-article","created":{"date-parts":[[2010,4,20]],"date-time":"2010-04-20T10:01:08Z","timestamp":1271757668000},"page":"247-255","source":"Crossref","is-referenced-by-count":149,"title":["Stem cell transplantation in multiple sclerosis: current status and future prospects"],"prefix":"10.1038","volume":"6","author":[{"name":"the Stem Cells in Multiple Sclerosis (STEMS) Consensus Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianvito","family":"Martino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin J. M.","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Baron","family":"Van Evercooren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,20]]},"reference":[{"key":"BFnrneurol201035_CR1","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1177\/1352458506071301","volume":"12","author":"R Saccardi","year":"2006","unstructured":"Saccardi, R.  et al. Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. Mult. Scler. 12, 814\u2013823 (2006).","journal-title":"Mult. Scler."},{"key":"BFnrneurol201035_CR2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/sj.bmt.1704892","volume":"35","author":"A Gratwohl","year":"2005","unstructured":"Gratwohl, A.  et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant. 35, 869\u2013879 (2005).","journal-title":"Bone Marrow Transplant."},{"key":"BFnrneurol201035_CR3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(09)70017-1","volume":"8","author":"RK Burt","year":"2009","unstructured":"Burt, R. K.  et al. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing\u2013remitting multiple sclerosis: a phase I\/II study. Lancet Neurol. 8, 244\u2013253 (2009).","journal-title":"Lancet Neurol."},{"key":"BFnrneurol201035_CR4","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S1474-4422(08)70138-8","volume":"7","author":"G Mancardi","year":"2008","unstructured":"Mancardi, G. & Saccardi, R. Autologous haematopoietic stem-cell transplantation in multiple sclerosis. Lancet Neurol. 7, 626\u2013636 (2008).","journal-title":"Lancet Neurol."},{"key":"BFnrneurol201035_CR5","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.it.2004.09.012","volume":"25","author":"RJ Fox","year":"2004","unstructured":"Fox, R. J. & Ransohoff, R. M. New directions in MS therapeutics: vehicles of hope. Trends Immunol. 25, 632\u2013636 (2004).","journal-title":"Trends Immunol."},{"key":"BFnrneurol201035_CR6","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston, A. & Coles, A. Multiple sclerosis. Lancet 372, 1502\u20131517 (2008).","journal-title":"Lancet"},{"key":"BFnrneurol201035_CR7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/WCO.0b013e32832b4ca1","volume":"22","author":"PS Giacomini","year":"2009","unstructured":"Giacomini, P. S., Darlington, P. J. & Bar-Or, A. Emerging multiple sclerosis disease-modifying therapies. Curr. Opin. Neurol. 22, 226\u2013232 (2009).","journal-title":"Curr. Opin. Neurol."},{"key":"BFnrneurol201035_CR8","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1523\/JNEUROSCI.5804-08.2009","volume":"29","author":"D Centonze","year":"2009","unstructured":"Centonze, D.  et al. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J. Neurosci. 29, 3442\u20133452 (2009).","journal-title":"J. Neurosci."},{"key":"BFnrneurol201035_CR9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2007.08.039","volume":"265","author":"J Palace","year":"2008","unstructured":"Palace, J. Neuroprotection and repair. J. Neurol. Sci. 265, 21\u201325 (2008).","journal-title":"J. Neurol. Sci."},{"key":"BFnrneurol201035_CR10","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/brain\/awl217","volume":"129","author":"P Patrikios","year":"2006","unstructured":"Patrikios, P.  et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129, 3165\u20133172 (2006).","journal-title":"Brain"},{"key":"BFnrneurol201035_CR11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2990.2007.00805.x","volume":"33","author":"R Patani","year":"2007","unstructured":"Patani, R., Balaratnam, M., Vora, A. & Reynolds, R. Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol. Appl. Neurobiol. 33, 277\u2013287 (2007).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BFnrneurol201035_CR12","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrn2480","volume":"9","author":"RJ Franklin","year":"2008","unstructured":"Franklin, R. J. & Ffrench-Constant, C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 9, 839\u2013855 (2008).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnrneurol201035_CR13","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1093\/brain\/awn198","volume":"131","author":"S Pluchino","year":"2008","unstructured":"Pluchino, S.  et al. Persistent inflammation alters the function of the endogenous brain stem cell compartment. Brain 131, 2564\u20132578 (2008).","journal-title":"Brain"},{"key":"BFnrneurol201035_CR14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.21581","volume":"65","author":"S Mi","year":"2009","unstructured":"Mi, S.  et al. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann. Neurol. 65, 304\u2013315 (2009).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201035_CR15","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1101\/gad.1806309","volume":"23","author":"SP Fancy","year":"2009","unstructured":"Fancy, S. P.  et al. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev. 23, 1571\u20131585 (2009).","journal-title":"Genes Dev."},{"key":"BFnrneurol201035_CR16","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/brain\/awn076","volume":"131","author":"M Dubois-Dalcq","year":"2008","unstructured":"Dubois-Dalcq, M.  et al. From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases. Brain 131, 1686\u20131700 (2008).","journal-title":"Brain"},{"key":"BFnrneurol201035_CR17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1517\/14712598.6.1.17","volume":"6","author":"A Uccelli","year":"2006","unstructured":"Uccelli, A., Zappia, E., Benvenuto, F., Frassoni, F. & Mancardi, G. Stem cells in inflammatory demyelinating disorders: a dual role for immunosuppression and neuroprotection. Expert Opin. Biol. Ther. 6, 17\u201322 (2006).","journal-title":"Expert Opin. Biol. Ther."},{"key":"BFnrneurol201035_CR18","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli, A., Moretta, L. & Pistoia, V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8, 726\u2013736 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrneurol201035_CR19","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","volume":"106","author":"E Zappia","year":"2005","unstructured":"Zappia, E.  et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106, 1755\u20131761 (2005).","journal-title":"Blood"},{"key":"BFnrneurol201035_CR20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ana.21076","volume":"61","author":"E Gerdoni","year":"2007","unstructured":"Gerdoni, E.  et al. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann. Neurol. 61, 219\u2013227 (2007).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201035_CR21","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.65.6.753","volume":"65","author":"I Kassis","year":"2008","unstructured":"Kassis, I.  et al. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch. Neurol. 65, 753\u2013761 (2008).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201035_CR22","doi-asserted-by":"crossref","first-page":"e5959","DOI":"10.1371\/journal.pone.0005959","volume":"4","author":"S Pluchino","year":"2009","unstructured":"Pluchino, S.  et al. Immune regulatory neural stem\/precursor cells protect from central nervous system autoimmunity by restraining dendritic cell function. PLoS One 4, e5959 (2009).","journal-title":"PLoS One"},{"key":"BFnrneurol201035_CR23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nature03889","volume":"436","author":"S Pluchino","year":"2005","unstructured":"Pluchino, S.  et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 436, 266\u2013271 (2005).","journal-title":"Nature"},{"key":"BFnrneurol201035_CR24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.21745","volume":"66","author":"S Pluchino","year":"2009","unstructured":"Pluchino, S.  et al. Human neural stem cells ameliorate autoimmune encephalomyelitis in non human primates. Ann. Neurol. 66, 343\u2013354 (2009).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201035_CR25","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.mcn.2003.08.009","volume":"24","author":"O Einstein","year":"2003","unstructured":"Einstein, O.  et al. Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis. Mol. Cell Neurosci. 24, 1074\u20131082 (2003).","journal-title":"Mol. Cell Neurosci."},{"key":"BFnrneurol201035_CR26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.expneurol.2005.11.007","volume":"198","author":"O Einstein","year":"2006","unstructured":"Einstein, O.  et al. Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis. Exp. Neurol. 198, 275\u2013284 (2006).","journal-title":"Exp. Neurol."},{"key":"BFnrneurol201035_CR27","doi-asserted-by":"crossref","first-page":"e3145","DOI":"10.1371\/journal.pone.0003145","volume":"3","author":"M Aharonowiz","year":"2008","unstructured":"Aharonowiz, M.  et al. Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis. PLoS ONE 3, e3145 (2008).","journal-title":"PLoS ONE"},{"key":"BFnrneurol201035_CR28","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1172\/JCI37914","volume":"119","author":"J Yang","year":"2009","unstructured":"Yang, J.  et al. Adult neural stem cells expressing IL-10 confer potent immunomodulation and remyelination in experimental autoimmune encephalitis. J. Clin. Invest. 119, 3678\u20133691 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol201035_CR29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.mcn.2008.07.007","volume":"39","author":"N Fainstein","year":"2008","unstructured":"Fainstein, N.  et al. Neural precursor cells inhibit multiple inflammatory signals. Mol. Cell Neurosci. 39, 335\u2013341 (2008).","journal-title":"Mol. Cell Neurosci."},{"key":"BFnrneurol201035_CR30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ana.21033","volume":"61","author":"O Einstein","year":"2007","unstructured":"Einstein, O.  et al. Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression. Ann. Neurol. 61, 209\u2013218 (2007).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201035_CR31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/glia.10159","volume":"41","author":"T Ben-Hur","year":"2003","unstructured":"Ben-Hur, T.  et al. Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis. Glia 41, 73\u201380 (2003).","journal-title":"Glia"},{"key":"BFnrneurol201035_CR32","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nature01552","volume":"422","author":"S Pluchino","year":"2003","unstructured":"Pluchino, S.  et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422, 688\u2013694 (2003).","journal-title":"Nature"},{"key":"BFnrneurol201035_CR33","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1146\/annurev.cellbio.21.012704.131525","volume":"21","author":"L Li","year":"2005","unstructured":"Li, L. & Xie, T. Stem cell niche: structure and function. Annu. Rev. Cell Dev. Biol. 21, 605\u2013631 (2005).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"BFnrneurol201035_CR34","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrn1908","volume":"7","author":"G Martino","year":"2006","unstructured":"Martino, G. & Pluchino, S. The therapeutic potential of neural stem cells. Nat. Rev. Neurosci. 7, 395\u2013406 (2006).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnrneurol201035_CR35","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.yexcr.2005.03.018","volume":"306","author":"CA Gregory","year":"2005","unstructured":"Gregory, C. A., Prockop, D. J. & Spees, J. L. Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation. Exp. Cell Res. 306, 330\u2013335 (2005).","journal-title":"Exp. Cell Res."},{"key":"BFnrneurol201035_CR36","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","volume":"371","author":"K Le Blanc","year":"2008","unstructured":"Le Blanc, K.  et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371, 1579\u20131586 (2008).","journal-title":"Lancet"},{"key":"BFnrneurol201035_CR37","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1182\/blood-2004-09-3696","volume":"105","author":"S Glennie","year":"2005","unstructured":"Glennie, S., Soeiro, I., Dyson, P. J., Lam, E. W. & Dazzi, F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105, 2821\u20132827 (2005).","journal-title":"Blood"},{"key":"BFnrneurol201035_CR38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","volume":"107","author":"A Corcione","year":"2006","unstructured":"Corcione, A.  et al. Human mesenchymal stem cells modulate B-cell functions. Blood 107, 367\u2013372 (2006).","journal-title":"Blood"},{"key":"BFnrneurol201035_CR39","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1073\/pnas.92.11.4857","volume":"92","author":"RF Pereira","year":"1995","unstructured":"Pereira, R. F.  et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc. Natl Acad. Sci. USA 92, 4857\u20134861 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol201035_CR40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jcp.21200","volume":"213","author":"AI Caplan","year":"2007","unstructured":"Caplan, A. I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell. Physiol. 213, 341\u2013347 (2007).","journal-title":"J. Cell. Physiol."},{"key":"BFnrneurol201035_CR41","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/35070587","volume":"410","author":"D Orlic","year":"2001","unstructured":"Orlic, D.  et al. Bone marrow cells regenerate infarcted myocardium. Nature 410, 701\u2013705 (2001).","journal-title":"Nature"},{"key":"BFnrneurol201035_CR42","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1089\/scd.2007.0197","volume":"17","author":"E Anghileri","year":"2008","unstructured":"Anghileri, E.  et al. Neuronal differentiation potential of human adipose-derived mesenchymal stem cells. Stem Cells Dev. 17, 909\u2013916 (2008).","journal-title":"Stem Cells Dev."},{"key":"BFnrneurol201035_CR43","doi-asserted-by":"crossref","first-page":"10711","DOI":"10.1073\/pnas.96.19.10711","volume":"96","author":"GC Kopen","year":"1999","unstructured":"Kopen, G. C., Prockop, D. J. & Phinney, D. G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc. Natl Acad. Sci. USA 96, 10711\u201310716 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol201035_CR44","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1634\/stemcells.2007-0637","volume":"25","author":"DG Phinney","year":"2007","unstructured":"Phinney, D. G. & Prockop, D. J. Concise review: mesenchymal stem\/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair\u2014current views. Stem Cells 25, 2896\u20132902 (2007).","journal-title":"Stem Cells"},{"key":"BFnrneurol201035_CR45","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3727\/096368908786516738","volume":"17","author":"DP Hunt","year":"2008","unstructured":"Hunt, D. P.  et al. Effects of direct transplantation of multipotent mesenchymal stromal\/stem cells into the demyelinated spinal cord. Cell Transplant. 17, 865\u2013873 (2008).","journal-title":"Cell Transplant."},{"key":"BFnrneurol201035_CR46","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/glia.20841","volume":"57","author":"L Bai","year":"2009","unstructured":"Bai, L.  et al. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 57, 1192\u20131203 (2009).","journal-title":"Glia"},{"key":"BFnrneurol201035_CR47","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3324\/haematol.11869","volume":"93","author":"N Sessarego","year":"2008","unstructured":"Sessarego, N.  et al. Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. Haematologica 93, 339\u2013346 (2008).","journal-title":"Haematologica"},{"key":"BFnrneurol201035_CR48","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1073\/pnas.132252399","volume":"99","author":"EM Horwitz","year":"2002","unstructured":"Horwitz, E. M.  et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc. Natl Acad. Sci. USA 99, 8932\u20138937 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol201035_CR49","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/10428199509056824","volume":"17","author":"HM Lazarus","year":"1995","unstructured":"Lazarus, H. M. Bone marrow transplantation in low-grade non-Hodgkin's lymphoma. Leuk. Lymphoma 17, 199\u2013210 (1995).","journal-title":"Leuk. Lymphoma"},{"key":"BFnrneurol201035_CR50","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2005.02.001","volume":"11","author":"HM Lazarus","year":"2005","unstructured":"Lazarus, H. M.  et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol. Blood Marrow Transplant. 11, 389\u2013398 (2005).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"BFnrneurol201035_CR51","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.clineuro.2008.02.008","volume":"110","author":"D Karussis","year":"2008","unstructured":"Karussis, D. & Kassis, I. The potential use of stem cells in multiple sclerosis: an overview of the preclinical experience. Clin. Neurol. Neurosurg. 110, 889\u2013896 (2008).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"BFnrneurol201035_CR52","first-page":"50","volume":"4","author":"M Mohyeddin Bonab","year":"2007","unstructured":"Mohyeddin Bonab, M.  et al. Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study. Iran J. Immunol. 4, 50\u201357 (2007).","journal-title":"Iran J. Immunol."},{"issue":"4","key":"BFnrneurol201035_CR53","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/1352458509359727","volume":"16","author":"Mark S Freedman","year":"2010","unstructured":"Freedman, M. S.  et al. The Therapeutic Potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: Consensus report of the International MSCT Study Group. Mult. Scler. doi:10.1177\/1352458509359727.","journal-title":"Multiple Sclerosis Journal"},{"key":"BFnrneurol201035_CR54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/35102174","volume":"414","author":"S Temple","year":"2001","unstructured":"Temple, S. The development of neural stem cells. Nature 414, 112\u2013117 (2001).","journal-title":"Nature"},{"key":"BFnrneurol201035_CR55","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1634\/stemcells.2007-0037","volume":"25","author":"LS Politi","year":"2007","unstructured":"Politi, L. S.  et al. Magnetic resonance-based tracking and quantification of intravenously injected neural stem cell accumulation in the brains of mice with experimental multiple sclerosis. Stem Cells 25, 2583\u20132592 (2007).","journal-title":"Stem Cells"},{"key":"BFnrneurol201035_CR56","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/mrm.21116","volume":"57","author":"T Ben-Hur","year":"2007","unstructured":"Ben-Hur, T.  et al. Serial in vivo MR tracking of magnetically labeled neural spheres transplanted in chronic EAE mice. Magn. Reson. Med. 57, 164\u2013171 (2007).","journal-title":"Magn. Reson. Med."},{"key":"BFnrneurol201035_CR57","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000112359","volume":"6","author":"F Lachapelle","year":"1983","unstructured":"Lachapelle, F.  et al. Transplantation of CNS fragments into the brain of shiverer mutant mice: extensive myelination by implanted oligodendrocytes. I. Immunohistochemical studies. Dev. Neurosci. 6, 325\u2013334 (1983).","journal-title":"Dev. Neurosci."},{"key":"BFnrneurol201035_CR58","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/362453a0","volume":"362","author":"AK Groves","year":"1993","unstructured":"Groves, A. K.  et al. Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells. Nature 362, 453\u2013455 (1993).","journal-title":"Nature"},{"key":"BFnrneurol201035_CR59","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1073\/pnas.96.7.4089","volume":"96","author":"SC Zhang","year":"1999","unstructured":"Zhang, S. C., Ge, B. & Duncan, I. D. Adult brain retains the potential to generate oligodendroglial progenitors with extensive myelination capacity. Proc. Natl Acad. Sci. USA 96, 4089\u20134094 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol201035_CR60","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.stem.2008.03.020","volume":"2","author":"MS Windrem","year":"2008","unstructured":"Windrem, M. S.  et al. Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse. Cell Stem Cell 2, 553\u2013565 (2008).","journal-title":"Cell Stem Cell"},{"key":"BFnrneurol201035_CR61","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm0197-54","volume":"3","author":"DR Archer","year":"1997","unstructured":"Archer, D. R., Cuddon, P. A., Lipsitz, D. & Duncan, I. D. Myelination of the canine central nervous system by glial cell transplantation: a model for repair of human myelin disease. Nat. Med. 3, 54\u201359 (1997).","journal-title":"Nat. Med."},{"key":"BFnrneurol201035_CR62","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/280395a0","volume":"280","author":"EJ Smith","year":"1979","unstructured":"Smith, E. J., Blakemore, W. F. & McDonald, W. I. Central remyelination restores secure conduction. Nature 280, 395\u2013396 (1979).","journal-title":"Nature"},{"key":"BFnrneurol201035_CR63","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1073\/pnas.91.1.53","volume":"91","author":"DA Utzschneider","year":"1994","unstructured":"Utzschneider, D. A., Archer, D. R., Kocsis, J. D., Waxman, S. G. & Duncan, I. D. Transplantation of glial cells enhances action potential conduction of amyelinated spinal cord axons in the myelin-deficient rat. Proc. Natl Acad. Sci. USA 91, 53\u201357 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol201035_CR64","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/brain\/120.1.27","volume":"120","author":"ND Jeffery","year":"1997","unstructured":"Jeffery, N. D. & Blakemore, W. F. Locomotor deficits induced by experimental spinal cord demyelination are abolished by spontaneous remyelination. Brain 120, 27\u201337 (1997).","journal-title":"Brain"},{"key":"BFnrneurol201035_CR65","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/135245859700300205","volume":"3","author":"RJ Franklin","year":"1997","unstructured":"Franklin, R. J. & Blakemore, W. F. To what extent is oligodendrocyte progenitor migration a limiting factor in the remyelination of multiple sclerosis lesions? Mult. Scler. 3, 84\u201387 (1997).","journal-title":"Mult. Scler."},{"key":"BFnrneurol201035_CR66","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/glia.20127","volume":"49","author":"GI Nistor","year":"2005","unstructured":"Nistor, G. I., Totoiu, M. O., Haque, N., Carpenter, M. K. & Keirstead, H. S. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 49, 385\u2013396 (2005).","journal-title":"Glia"},{"key":"BFnrneurol201035_CR67","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1242\/dev.029447","volume":"136","author":"BY Hu","year":"2009","unstructured":"Hu, B. Y., Du, Z. W., Li, X. J., Ayala, M. & Zhang, S. C. Human oligodendrocytes from embryonic stem cells: conserved SHH signaling networks and divergent FGF effects. Development 136, 1443\u20131452 (2009).","journal-title":"Development"},{"key":"BFnrneurol201035_CR68","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1523\/JNEUROSCI.19-17-07529.1999","volume":"19","author":"HS Keirstead","year":"1999","unstructured":"Keirstead, H. S.  et al. Polysialylated neural cell adhesion molecule-positive CNS precursors generate both oligodendrocytes and Schwann cells to remyelinate the CNS after transplantation. J. Neurosci. 19, 7529\u20137536 (1999).","journal-title":"J. Neurosci."},{"key":"BFnrneurol201035_CR69","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/exnr.1997.6592","volume":"147","author":"JP Hammang","year":"1997","unstructured":"Hammang, J. P., Archer, D. R. & Duncan, I. D. Myelination following transplantation of EGF-responsive neural stem cells into a myelin-deficient environment. Exp. Neurol. 147, 84\u201395 (1997).","journal-title":"Exp. Neurol."},{"key":"BFnrneurol201035_CR70","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.10446","volume":"53","author":"M Kerschensteiner","year":"2003","unstructured":"Kerschensteiner, M., Stadelmann, C., Dechant, G., Wekerle, H. & Hohlfeld, R. Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases. Ann. Neurol. 53, 292\u2013304 (2003).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201035_CR71","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/455436b","volume":"455","author":"EC Hayden","year":"2008","unstructured":"Hayden, E. C. California institute to help stem-cell biotechs. Nature 455, 436\u2013437 (2008).","journal-title":"Nature"},{"key":"BFnrneurol201035_CR72","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nrn1829","volume":"7","author":"FJ Muller","year":"2006","unstructured":"Muller, F. J., Snyder, E. Y. & Loring, J. F. Gene therapy: can neural stem cells deliver? Nat. Rev. Neurosci. 7, 75\u201384 (2006).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnrneurol201035_CR73","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663\u2013676 (2006).","journal-title":"Cell"},{"key":"BFnrneurol201035_CR74","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0896-6273(00)00080-5","volume":"28","author":"RJ Franklin","year":"2000","unstructured":"Franklin, R. J. & Barnett, S. C. Olfactory ensheathing cells and CNS regeneration: the sweet smell of success? Neuron 28, 15\u201318 (2000).","journal-title":"Neuron"},{"key":"BFnrneurol201035_CR75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11068-005-5048-6","volume":"34","author":"AJ Vincent","year":"2005","unstructured":"Vincent, A. J., West, A. K. & Chuah, M. I. Morphological and functional plasticity of olfactory ensheathing cells. J. Neurocytol. 34, 65\u201380 (2005).","journal-title":"J. Neurocytol."},{"key":"BFnrneurol201035_CR76","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/(SICI)1098-1136(199607)17:3<217::AID-GLIA4>3.0.CO;2-Y","volume":"17","author":"RJ Franklin","year":"1996","unstructured":"Franklin, R. J., Gilson, J. M., Franceschini, I. A. & Barnett, S. C. Schwann cell-like myelination following transplantation of an olfactory bulb-ensheathing cell line into areas of demyelination in the adult CNS. Glia 17, 217\u2013224 (1996).","journal-title":"Glia"},{"key":"BFnrneurol201035_CR77","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1093\/brain\/123.8.1581","volume":"123","author":"SC Barnett","year":"2000","unstructured":"Barnett, S. C.  et al. Identification of a human olfactory ensheathing cell that can effect transplant-mediated remyelination of demyelinated CNS axons. Brain 123, 1581\u20131588 (2000).","journal-title":"Brain"},{"key":"BFnrneurol201035_CR78","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1523\/JNEUROSCI.18-16-06176.1998","volume":"18","author":"T Imaizumi","year":"1998","unstructured":"Imaizumi, T., Lankford, K. L., Waxman, S. G., Greer, C. A. & Kocsis, J. D. Transplanted olfactory ensheathing cells remyelinate and enhance axonal conduction in the demyelinated dorsal columns of the rat spinal cord. J. Neurosci. 18, 6176\u20136185 (1998).","journal-title":"J. Neurosci."},{"key":"BFnrneurol201035_CR79","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/(SICI)1098-1136(200005)30:3<209::AID-GLIA1>3.0.CO;2-8","volume":"30","author":"T Kato","year":"2000","unstructured":"Kato, T., Honmou, O., Uede, T., Hashi, K. & Kocsis, J. D. Transplantation of human olfactory ensheathing cells elicits remyelination of demyelinated rat spinal cord. Glia 30, 209\u2013218 (2000).","journal-title":"Glia"},{"key":"BFnrneurol201035_CR80","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/exnr.2002.7936","volume":"176","author":"PM Smith","year":"2002","unstructured":"Smith, P. M., Lakatos, A., Barnett, S. C., Jeffery, N. D. & Franklin, R. J. Cryopreserved cells isolated from the adult canine olfactory bulb are capable of extensive remyelination following transplantation into the adult rat CNS. Exp. Neurol. 176, 402\u2013406 (2002).","journal-title":"Exp. Neurol."},{"key":"BFnrneurol201035_CR81","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/jnr.20817","volume":"83","author":"C Deng","year":"2006","unstructured":"Deng, C.  et al. Survival and migration of human and rat olfactory ensheathing cells in intact and injured spinal cord. J. Neurosci. Res. 83, 1201\u20131212 (2006).","journal-title":"J. Neurosci. Res."},{"key":"BFnrneurol201035_CR82","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0014-4886(03)00270-X","volume":"184","author":"A Lakatos","year":"2003","unstructured":"Lakatos, A., Barnett, S. C. & Franklin, R. J. Olfactory ensheathing cells induce less host astrocyte response and chondroitin sulphate proteoglycan expression than Schwann cells following transplantation into adult CNS white matter. Exp. Neurol. 184, 237\u2013246 (2003).","journal-title":"Exp. Neurol."},{"key":"BFnrneurol201035_CR83","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1089\/neu.2005.22.1282","volume":"22","author":"ND Jeffery","year":"2005","unstructured":"Jeffery, N. D., Lakatos, A. & Franklin, R. J. Autologous olfactory glial cell transplantation is reliable and safe in naturally occurring canine spinal cord injury. J. Neurotrauma 22, 1282\u20131293 (2005).","journal-title":"J. Neurotrauma"},{"key":"BFnrneurol201035_CR84","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1093\/brain\/awh657","volume":"128","author":"F Feron","year":"2005","unstructured":"Feron, F.  et al. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain 128, 2951\u20132960 (2005).","journal-title":"Brain"},{"key":"BFnrneurol201035_CR85","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/266068a0","volume":"266","author":"WF Blakemore","year":"1977","unstructured":"Blakemore, W. F. Remyelination of CNS axons by Schwann cells transplanted from the sciatic nerve. Nature 266, 68\u201369 (1977).","journal-title":"Nature"},{"key":"BFnrneurol201035_CR86","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00019052-200406000-00003","volume":"17","author":"S Pluchino","year":"2004","unstructured":"Pluchino, S., Furlan, R. & Martino, G. Cell-based remyelinating therapies in multiple sclerosis: evidence from experimental studies. Curr. Opin. Neurol. 17, 247\u2013255 (2004).","journal-title":"Curr. Opin. Neurol."},{"key":"BFnrneurol201035_CR87","doi-asserted-by":"crossref","unstructured":"Zujovic, V.  et al. Boundary cap cells are highly competitive for CNS remyelination: fast migration and efficient differentiation in PNS and CNS myelin-forming cells. Stem Cells doi: 10.1002\/stem.290.","DOI":"10.1002\/stem.290"},{"key":"BFnrneurol201035_CR88","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1093\/brain\/awm125","volume":"130","author":"A Woodhoo","year":"2007","unstructured":"Woodhoo, A.  et al. Schwann cell precursors: a favourable cell for myelin repair in the central nervous system. Brain 130, 2175\u20132185 (2007).","journal-title":"Brain"},{"key":"BFnrneurol201035_CR89","doi-asserted-by":"crossref","first-page":"6651","DOI":"10.1523\/JNEUROSCI.1007-06.2006","volume":"26","author":"IA McKenzie","year":"2006","unstructured":"McKenzie, I. A., Biernaskie, J., Toma, J. G., Midha, R. & Miller, F. D. Skin-derived precursors generate myelinating Schwann cells for the injured and dysmyelinated nervous system. J. Neurosci. 26, 6651\u20136660 (2006).","journal-title":"J. Neurosci."},{"key":"BFnrneurol201035_CR90","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1634\/stemcells.2007-0281","volume":"26","author":"DP Hunt","year":"2008","unstructured":"Hunt, D. P.  et al. A highly enriched niche of precursor cells with neuronal and glial potential within the hair follicle dermal papilla of adult skin. Stem Cells 26, 163\u2013172 (2008).","journal-title":"Stem Cells"},{"key":"BFnrneurol201035_CR91","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/nbt1365","volume":"25","author":"G Lee","year":"2007","unstructured":"Lee, G.  et al. Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat. Biotechnol. 25, 1468\u20131475 (2007).","journal-title":"Nat. Biotechnol."},{"key":"BFnrneurol201035_CR92","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1212\/01.wnl.0000316436.13659.80","volume":"71","author":"DJ Mathews","year":"2008","unstructured":"Mathews, D. J.  et al. Cell-based interventions for neurologic conditions: ethical challenges for early human trials. Neurology 71, 288\u2013293 (2008).","journal-title":"Neurology"},{"key":"BFnrneurol201035_CR93","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.stem.2008.11.009","volume":"3","author":"I Hyun","year":"2008","unstructured":"Hyun, I.  et al. New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell 3, 607\u2013609 (2008).","journal-title":"Cell Stem Cell"},{"key":"BFnrneurol201035_CR94","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","volume":"338","author":"BD Trapp","year":"1998","unstructured":"Trapp, B. D.  et al. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338, 278\u2013285 (1998).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol201035_CR95","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","volume":"359","author":"A Compston","year":"2002","unstructured":"Compston, A. & Coles, A. Multiple sclerosis. Lancet 359, 1221\u20131231 (2002).","journal-title":"Lancet"},{"key":"BFnrneurol201035_CR96","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","volume":"343","author":"JH Noseworthy","year":"2000","unstructured":"Noseworthy, J. H., Lucchinetti, C., Rodriguez, M. & Weinshenker, B. G. Multiple sclerosis. N. Engl. J. Med. 343, 938\u2013952 (2000).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol201035_CR97","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(96)90807-7","volume":"347","author":"AD Sadovnick","year":"1996","unstructured":"Sadovnick, A. D., Ebers, G. C., Dyment, D. A. & Risch, N. J. Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet 347, 1728\u20131730 (1996).","journal-title":"Lancet"},{"key":"BFnrneurol201035_CR98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-5728(94)90225-9","volume":"54","author":"GC Ebers","year":"1994","unstructured":"Ebers, G. C. & Sadovnick, A. D. The role of genetic factors in multiple sclerosis susceptibility. J. Neuroimmunol. 54, 1\u201317 (1994).","journal-title":"J. Neuroimmunol."},{"key":"BFnrneurol201035_CR99","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1017\/S0317167100047351","volume":"20","author":"AD Sadovnick","year":"1993","unstructured":"Sadovnick, A. D. & Ebers, G. C. Epidemiology of multiple sclerosis: a critical overview. Can. J. Neurol. Sci. 20, 17\u201329 (1993).","journal-title":"Can. J. Neurol. Sci."},{"key":"BFnrneurol201035_CR100","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1242\/dev.020867","volume":"136","author":"K Hochedlinger","year":"2009","unstructured":"Hochedlinger, K. & Plath, K. Epigenetic reprogramming and induced pluripotency. Development 136, 509\u2013523 (2009).","journal-title":"Development"},{"key":"BFnrneurol201035_CR101","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.cell.2008.01.015","volume":"132","author":"R Jaenisch","year":"2008","unstructured":"Jaenisch, R. & Young, R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132, 567\u2013582 (2008).","journal-title":"Cell"},{"key":"BFnrneurol201035_CR102","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici, M.  et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315\u2013317 (2006).","journal-title":"Cytotherapy"}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2010.35.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2010.35","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2010.35.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:58:32Z","timestamp":1684472312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2010.35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,20]]},"references-count":102,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["BFnrneurol201035"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2010.35","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,20]]}}}